Cathy Eng: Critical information from Journal of Clinical Oncology

Cathy Eng shared a post by Syed Ahmad, Director University of Cincinnati Cancer Center, on LinkedIn and added:

“SO glad to see this out! CRITICAL information from Journal of Clinical Oncology, Nuh Rahbari, and Florian Lordick.

• The PRIMARY colorectal tumor should NOT be resected unless needed.
• NO difference in OS.”

Quoting Syed Ahmad’s post:

“Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials.”

Source: Cathy Eng/X and Syed Ahmad/X

Cathy Eng is a Professor of Medicine, Hematology and Oncology, and is the Co-Director of GI Oncology and Co-Leader of the Gastrointestinal Cancer Research Program at the Vanderbilt-Ingram Cancer Center. She also holds the David H. Johnson Endowed Chair of Surgical and Medical Oncology. Dr. Eng was previously a Professor of Medical Oncology at The University of Texas MD Anderson Cancer Center.

Her primary clinical research interests include clinical trials involving innovative drugs for the treatment of colorectal, anal, and appendiceal cancers. She has a specific interest in young colorectal cancer patients as well as the role of immunotherapy in HPV-associated cancers.

Nationally, Dr. Eng has served in multiple leadership roles for ASCO, ASCO GI, ECOG, and the NCI Rectal/Anal Task Force. She has most recently been chosen to serve as the Vice-Chair for the SWOG GI Committee and the NCI GI Steering Committee.